Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I single-dose study of SK-0348 transdermal patch in healthy adult males
jRCT2071220001Phase 1Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of SK-0348 in None (4 arms), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoint: Safety, pharmacokinetics, and pharmacodynamics. Started Apr 2022; status: completed.
02
Drugs
SK-0348
Beyond the preview
Go deeper on jRCT2071220001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220001.